SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

BRIEF-Hubei Biocause Pharma Posts Insurance JV's Premium Income For Jan-May

reuters.com · 06/10/2022 04:08
BRIEF-Hubei Biocause Pharma Posts Insurance JV's Premium Income For Jan-May

- Hubei Biocause Pharmaceutical Co Ltd 000627.SZ:

  • SAYS LIFE INSURANCE JV'S JAN-MAY PREMIUM INCOME AT ABOUT 19.3 BILLION YUAN ($2.89 billion)

Source text

Further company coverage: 000627.SZ


($1 = 6.6875 Chinese yuan renminbi)


(Reporting by Hong Kong newsroom)

((Ella.Cao@thomsonreuters.com;))